Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Buildings And Improvements : ₹0 Mil (As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is Sun Pharmaceuticals Industries Buildings And Improvements?

Sun Pharmaceuticals Industries's annual buildings and improvements declined from Mar. 2023 (₹68,197 Mil) to Mar. 2024 (₹68,027 Mil) and declined from Mar. 2024 (₹68,027 Mil) to Mar. 2025 (₹0 Mil).

Sun Pharmaceuticals Industries Buildings And Improvements Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Buildings And Improvements Chart

Sun Pharmaceuticals Industries Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Buildings And Improvements

Get a 7-Day Free Trial

59,372.20

60,478.10

68,196.90

68,026.60

Sun Pharmaceuticals Industries Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial															68,026.60	-	-	-	-

Sun Pharmaceuticals Industries Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Sun Pharmaceuticals Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) » Definitions » Buildings And Improvements

Traded in Other Exchanges

524715:India

Address

Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063

Website

https://www.sunpharma.com

Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.

Sun Pharmaceuticals Industries Headlines

No Headlines